Earnings Scheduled For March 9, 2023
Companies Reporting Before The Bell
• Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.
ANI Pharmaceuticals Sees FY23 Adjusted EPS of $2.09-$2.59 Vs. Consensus Of $2.62; Forecasts Revenues Of $360M-$385M Vs. $352.49M Estimate
2023 Cortrophin specific revenue guidance is between $80.0 million to $90.0 million, representing 92% to 116% growth as compared to $41.7 million recognized in
Guggenheim Creates Bullish Pitch For ANI Pharma On Progress With Cortrophin Launch
Guggenheim launched its coverage on ANI Pharmaceuticals Inc (NASDAQ:ANIP) with a price target of $55 and a Buy recommendation citing a “bullish view”…
ANI Pharmaceuticals Announces FDA Approval And Launch Of Levocarnitine Tablets USP
ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Levocarnitine Tablets
ANI Pharmaceuticals’s Return On Capital Employed Overview
According to data from Benzinga Pro, during Q3, ANI Pharmaceuticals‘s (NASDAQ:ANIP) reported sales totaled $83.82 million. Despite a…
HC Wainwright & Co. Initiates Coverage On ANI Pharmaceuticals with Buy Rating, Announces Price Target of $50
HC Wainwright & Co. analyst Oren Livnat initiates coverage on ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy rating and announces Price Target of $50.
Recap Of Tuesday’s Biotech Catalysts – End Of the Day Summary
The U.S. Food and Drug Administration (FDA) has approved Amphastar’s (NASDAQ:AMPH) New Drug Application (ND”) for Epinephrine injection…
ANI Pharmaceuticals Q1 EPS $(0.12) Misses $0.09 Estimate, Sales $64.50M Miss $65.03M Estimate
ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $0.09 by 233.33 percent. This is a 111.54 percent decrease over earnings of $1.04 per share
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell
• The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.